Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Alan Fogelman

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Living Beings

Disorders

Phenomena

Oxidation-Reduction

Concepts & Ideas

Atherogenic Diet

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Charles-Schoeman Christina; Watanabe Junji; Lee Yuen Yin; Furst Daniel E; Amjadi Sogol; Elashoff David; Park Grace; McMahon Maureen; Paulus Harold E; Fogelman Alan M; Reddy Srinivasa T
Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis.
Navab Mohamad; Ruchala Piotr; Waring Alan J; Lehrer Robert I; Hama Susan; Hough Greg; Palgunachari Mayakonda N; Anantharamaiah G M; Fogelman Alan M
A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.
Navab Mohamad; Reddy Srinivasa T; Van Lenten Brian J; Anantharamaiah G M; Fogelman Alan M
The role of dysfunctional HDL in atherosclerosis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Alan Fogelman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Charles-Schoeman Christina; Watanabe Junji; Lee Yuen Yin; Furst Daniel E; Amjadi Sogol; Elashoff David; Park Grace; McMahon Maureen; Paulus Harold E; Fogelman Alan M; Reddy Srinivasa T
Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis.
Arthritis and rheumatism 2009;60(10):2870-9.
2009: Navab Mohamad; Ruchala Piotr; Waring Alan J; Lehrer Robert I; Hama Susan; Hough Greg; Palgunachari Mayakonda N; Anantharamaiah G M; Fogelman Alan M
A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.
Journal of lipid research 2009;50(8):1538-47.
2009: Navab Mohamad; Reddy Srinivasa T; Van Lenten Brian J; Anantharamaiah G M; Fogelman Alan M
The role of dysfunctional HDL in atherosclerosis.
Journal of lipid research 2009;50 Suppl():S145-9.
2008: Van Lenten Brian J; Navab Mohamad; Anantharamaiah G M; Buga Georgette M; Reddy Srinivasa T; Fogelman Alan M
Multiple indications for anti-inflammatory apolipoprotein mimetic peptides.
Current opinion in investigational drugs (London, England : 2000) 2008;9(11):1157-62.
2008: Van Lenten Brian J; Wagner Alan C; Jung Chun-Ling; Ruchala Piotr; Waring Alan J; Lehrer Robert I; Watson Andrew D; Hama Susan; Navab Mohamad; Anantharamaiah G M; Fogelman Alan M
Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I.
Journal of lipid research 2008;49(11):2302-11.
2008: Cruz Daniel; Watson Andrew D; Miller Christopher S; Montoya Dennis; Ochoa Maria-Teresa; Sieling Peter A; Gutierrez Miguel A; Navab Mohamad; Reddy Srinivasa T; Witztum Joseph L; Fogelman Alan M; Rea Thomas H; Eisenberg David; Berliner Judith; Modlin Robert L
Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy.
The Journal of clinical investigation 2008;118(8):2917-28.
2008: Reddy Srinivasa T; Devarajan Asokan; Bourquard Noam; Shih Diana; Fogelman Alan M
Is it just paraoxonase 1 or are other members of the paraoxonase gene family implicated in atherosclerosis?
Current opinion in lipidology 2008;19(4):405-8.
2008: Charles-Schoeman Christina; Banquerigo Mona Lisa; Hama Susan; Navab Mohamad; Park Grace S; Van Lenten Brian J; Wagner Alan C; Fogelman Alan M; Brahn Ernest
Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis.
Clinical immunology (Orlando, Fla.) 2008;127(2):234-44.
2008: Navab Mohamad; Anantharamaiah G M; Reddy Srinivasa T; Van Lenten Brian J; Fogelman Alan M
Apo A-1 mimetic peptides as atheroprotective agents in murine models.
Current drug targets 2008;9(3):204-9.
2008: Navab Mohamad; Anantharamaiah G M; Fogelman Alan M
The effect of apolipoprotein mimetic peptides in inflammatory disorders other than atherosclerosis.
Trends in cardiovascular medicine 2008;18(2):61-6.
2008: Buga Georgette M; Frank Joy S; Mottino Giuliano A; Hakhamian Ashkan; Narasimha Ajay; Watson Andrew D; Yekta Babak; Navab Mohamad; Reddy Srinivasa T; Anantharamaiah G M; Fogelman Alan M
D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet.
Journal of lipid research 2008;49(1):192-205.
2007: Van Lenten Brian J; Wagner Alan C; Navab Mohamad; Anantharamaiah G M; Hama Susan; Reddy Srinivasa T; Fogelman Alan M
Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits.
Journal of lipid research 2007;48(11):2344-53.
2007: Anantharamaiah G M; Mishra Vinod K; Garber David W; Datta Geeta; Handattu Shaila P; Palgunachari Mayakonda N; Chaddha Manjula; Navab Mohamad; Reddy Srinivasa T; Segrest Jere P; Fogelman Alan M
Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides.
Journal of lipid research 2007;48(9):1915-23.
2007: Narasimha Ajay; Watanabe Junji; Lin James A; Hama Susan; Langenbach Robert; Navab Mohamad; Fogelman Alan M; Reddy Srinivasa T
A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors.
Prostaglandins & other lipid mediators 2007;84(1-2):24-33.
2007: Ansell Benjamin J; Fonarow Gregg C; Fogelman Alan M
The paradox of dysfunctional high-density lipoprotein.
Current opinion in lipidology 2007;18(4):427-34.
2007: Watanabe Junji; Chou Katherine J; Liao James C; Miao Yunan; Meng Hsiang-Hui; Ge Helen; Grijalva Victor; Hama Susan; Kozak Kathy; Buga Georgette; Whitelegge Julian P; Lee Terry D; Farias-Eisner Robin; Navab Mohamad; Fogelman Alan M; Reddy Srinivasa T
Differential association of hemoglobin with proinflammatory high density lipoproteins in atherogenic/hyperlipidemic mice. A novel biomarker of atherosclerosis.
The Journal of biological chemistry 2007;282(32):23698-707.
2007: Charles-Schoeman Christina; Khanna Dinesh; Furst Daniel E; McMahon Maureen; Reddy Srinivasa T; Fogelman Alan M; Paulus Harold E; Park Grace S; Gong Timothy; Ansell Benjamin J
Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study.
The Journal of rheumatology 2007;34(7):1459-64.
2007: Ng Carey J; Bourquard Noam; Hama Susan Y; Shih Diana; Grijalva Victor R; Navab Mohamad; Fogelman Alan M; Reddy Srinivasa T
Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(6):1368-74.
2007: Shih Diana M; Xia Yu-Rong; Wang Xu-Ping; Wang Susanna S; Bourquard Noam; Fogelman Alan M; Lusis Aldons J; Reddy Srinivasa T
Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice.
Circulation research 2007;100(8):1200-7.
2007: Ansell Benjamin J; Fonarow Gregg C; Navab Mohamad; Fogelman Alan M
Modifying the anti-inflammatory effects of high-density lipoprotein.
Current atherosclerosis reports 2007;9(1):57-63.
2006: Navab Mohamad; Anantharamaiah G M; Reddy Srinivasa T; Fogelman Alan M
Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention.
Nature clinical practice. Cardiovascular medicine 2006;3(10):540-7.
2006: Ng Carey J; Bourquard Noam; Grijalva Victor; Hama Susan; Shih Diana M; Navab Mohamad; Fogelman Alan M; Lusis Aldons J; Young Stephen; Reddy Srinivasa T
Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2.
The Journal of biological chemistry 2006;281(40):29491-500.
2006: Buga Georgette M; Frank Joy S; Mottino Giuliano A; Hendizadeh Michael; Hakhamian Ashkan; Tillisch Jan H; Reddy Srinivasa T; Navab Mohamad; Anantharamaiah G M; Ignarro Louis J; Fogelman Alan M
D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet.
Journal of lipid research 2006;47(10):2148-60.
2006: Navab Mohamad; Anantharamaiah Gattadahalli M; Reddy Srinivasa T; Van Lenten Brian J; Ansell Benjamin J; Fogelman Alan M
Mechanisms of disease: proatherogenic HDL--an evolving field.
Nature clinical practice. Endocrinology & metabolism 2006;2(9):504-11.
2006: Ansell Benjamin J; Fonarow Gregg C; Fogelman Alan M
High-density lipoprotein: is it always atheroprotective?
Current atherosclerosis reports 2006;8(5):405-11.
2006: Van Lenten Brian J; Reddy Srinivasa T; Navab Mohamad; Fogelman Alan M
Understanding changes in high density lipoproteins during the acute phase response.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(8):1687-8.
2006: Navab Mohamad; Anantharamaiah G M; Reddy Srinivasa T; Van Lenten Brian J; Datta Geeta; Garber David; Fogelman Alan M
Potential clinical utility of high-density lipoprotein-mimetic peptides.
Current opinion in lipidology 2006;17(4):440-4.
2006: Anantharamaiah Gm; Navab Mohamad; Reddy Srinivasa T; Garber David W; Datta Geeta; Gupta Himanshu; White C Roger; Handattu Shaila P; Palgunachari Mayakonda N; Chaddha Manjula; Mishra Vinod K; Segrest Jere P; Fogelman Alan M
Synthetic peptides: managing lipid disorders.
Current opinion in lipidology 2006;17(3):233-7.
2006: Reddy Srinivasa T; Anantharamaiah G M; Navab Mohamad; Hama Susan; Hough Gregory; Grijalva Victor; Garber David W; Datta Geeta; Fogelman Alan M
Oral amphipathic peptides as therapeutic agents.
Expert opinion on investigational drugs 2006;15(1):13-21.
2005: Ansell Benjamin J; Watson Karol E; Fogelman Alan M; Navab Mohamad; Fonarow Gregg C
High-density lipoprotein function recent advances.
Journal of the American College of Cardiology 2005;46(10):1792-8.
2005: Navab Mohamad; Anantharamaiah G M; Reddy Srinivasa T; Hama Susan; Hough Greg; Frank Joy S; Grijalva Victor R; Ganesh Vannakambadi K; Mishra Vinod K; Palgunachari Mayakonda N; Fogelman Alan M
Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice.
Circulation research 2005;97(6):524-32.
2005: Navab Mohamad; Anantharamaiah G M; Reddy Srinivasa T; Van Lenten Brian J; Wagner Alan C; Hama Susan; Hough Greg; Bachini Eugene; Garber David W; Mishra Vinod K; Palgunachari Mayakonda N; Fogelman Alan M
An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(9):1932-7.
2005: Navab Mohamad; Anantharamaiah G M; Hama Susan; Hough Greg; Reddy Srinivasa T; Frank Joy S; Garber David W; Handattu Shaila; Fogelman Alan M
D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(7):1426-32.
2005: Navab Mohamad; Anantharamaiah G M; Reddy Srinivasa T; Hama Susan; Hough Greg; Grijalva Victor R; Yu Nicholas; Ansell Benjamin J; Datta Geeta; Garber David W; Fogelman Alan M
Apolipoprotein A-I mimetic peptides.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(7):1325-31.
2005: Navab Mohamad; Anantharamaiah G M; Fogelman Alan M
The role of high-density lipoprotein in inflammation.
Trends in cardiovascular medicine 2005;15(4):158-61.
2005: Navab Mohamad; Ananthramaiah G M; Reddy Srinivasa T; Van Lenten Brian J; Ansell Benjamin J; Hama Susan; Hough Greg; Bachini Eugene; Grijalva Victor R; Wagner Alan C; Shaposhnik Zory; Fogelman Alan M
The double jeopardy of HDL.
Annals of medicine 2005;37(3):173-8.
2004: Navab Mohamad; Anantharamaiah G M; Reddy Srinivasa T; Van Lenten Brian J; Datta Geeta; Garber David; Fogelman Alan M
Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal.
Current opinion in lipidology 2004;15(6):645-9.
2004: Ansell Benjamin J; Navab Mohamad; Watson Karol E; Fonarow Gregg C; Fogelman Alan M
Anti-inflammatory properties of HDL.
Reviews in endocrine & metabolic disorders 2004;5(4):351-8.
2004: Van Lenten Brian J; Wagner Alan C; Navab Mohamad; Anantharamaiah G M; Hui Eric Ka-Wai; Nayak Debi P; Fogelman Alan M
D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes.
Circulation 2004;110(20):3252-8.
2004: Lusis Aldons J; Fogelman Alan M; Fonarow Gregg C
Genetic basis of atherosclerosis: part II: clinical implications.
Circulation 2004;110(14):2066-71.
2004: Lusis Aldons J; Fogelman Alan M; Fonarow Gregg C
Genetic basis of atherosclerosis: part I: new genes and pathways.
Circulation 2004;110(13):1868-73.
2004: Reddy Srinivasa T; Nguyen Julie T; Grijalva Victor; Hough Greg; Hama Susan; Navab Mohamad; Fogelman Alan M
Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(9):1676-81.
2004: Navab Mohamad; Anantharamaiah G M; Reddy Srinivasa T; Hama Susan; Hough Greg; Grijalva Victor R; Wagner Alan C; Frank Joy S; Datta Geeta; Garber David; Fogelman Alan M
Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
Circulation 2004;109(25):3215-20.
2004: Datta Geeta; Epand Raquel F; Epand Richard M; Chaddha Manjula; Kirksey Matthew A; Garber David W; Lund-Katz Sissel; Phillips Michael C; Hama Susan; Navab Mohamad; Fogelman Alan M; Palgunachari Mayakonda N; Segrest Jere P; Anantharamaiah G M
Aromatic residue position on the nonpolar face of class a amphipathic helical peptides determines biological activity.
The Journal of biological chemistry 2004;279(25):26509-17.
2004: Navab Mohamad; Ananthramaiah G M; Reddy Srinivasa T; Van Lenten Brian J; Ansell Benjamin J; Fonarow Gregg C; Vahabzadeh Kambiz; Hama Susan; Hough Greg; Kamranpour Naeimeh; Berliner Judith A; Lusis Aldons J; Fogelman Alan M
The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.
Journal of lipid research 2004;45(6):993-1007.
2004: Navab Mohamad; Reddy Srinivasa T; Van Lenten Brian J; Fogelman Alan M
Apparent paradox of low-fat "healthy" diets increasing plasma levels of oxidized low-density lipoprotein and lipoprotein(a).
Arteriosclerosis, thrombosis, and vascular biology 2004;24(3):392-3.
2003: Ansell Benjamin J; Navab Mohamad; Hama Susan; Kamranpour Naeimeh; Fonarow Gregg; Hough Greg; Rahmani Shirin; Mottahedeh Rachel; Dave Ravi; Reddy Srinivasa T; Fogelman Alan M
Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
Circulation 2003;108(22):2751-6.
2003: Castrillo Antonio; Joseph Sean B; Vaidya Sagar A; Haberland Margaret; Fogelman Alan M; Cheng Genhong; Tontonoz Peter
Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism.
Molecular cell 2003;12(4):805-16.
2003: Navab Mohamad; Hama Susan; Hough Greg; Fogelman Alan M
Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice.
Circulation 2003;108(14):1735-9.
2003: Navab Mohamad; Anantharamaiah G M; Reddy Srinivasa T; Van Lenten Brian J; Hough Greg; Wagner Alan; Nakamura Kenta; Garber David W; Datta Geeta; Segrest Jere P; Hama Susan; Fogelman Alan M
Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis.
Current opinion in investigational drugs (London, England : 2000) 2003;4(9):1100-4.
2002: Reddy Srinivasa T; Hama Susan; Ng Carey; Grijalva Victor; Navab Mohamad; Fogelman Alan M
ATP-binding cassette transporter 1 participates in LDL oxidation by artery wall cells.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(11):1877-83.
2002: Van Lenten Brian J; Wagner Alan C; Anantharamaiah G M; Garber David W; Fishbein Michael C; Adhikary Lopa; Nayak Debi P; Hama Susan; Navab Mohamad; Fogelman Alan M
Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide.
Circulation 2002;106(9):1127-32.
2002: Navab Mohamad; Hama Susan Y; Reddy Srinu T; Ng Carey J; Van Lenten Brian J; Laks Hillel; Fogelman Alan M;
Oxidized lipids as mediators of coronary heart disease.
Current opinion in lipidology 2002;13(4):363-72.
2002: Reddy Srinivasa T; Grijalva Victor; Ng Carey; Hassan Khaled; Hama Susan; Mottahedeh Rachel; Wadleigh David J; Navab Mohamad; Fogelman Alan M
Identification of genes induced by oxidized phospholipids in human aortic endothelial cells.
Vascular pharmacology 2002;38(4):211-8.
2002: Navab Mohamad; Anantharamaiah G M; Hama Susan; Garber David W; Chaddha Manjula; Hough Greg; Lallone Roger; Fogelman Alan M
Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol.
Circulation 2002;105(3):290-2.
2001: Navab M; Van Lenten B J; Reddy S T; Fogelman A M
High-density lipoprotein and the dynamics of atherosclerotic lesions.
Circulation 2001;104(20):2386-7.
2001: Ng C J; Wadleigh D J; Gangopadhyay A; Hama S; Grijalva V R; Navab M; Fogelman A M; Reddy S T
Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein.
The Journal of biological chemistry 2001;276(48):44444-9.
2001: Navab M; Hama S Y; Hough G P; Subbanagounder G; Reddy S T; Fogelman A M
A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids.
Journal of lipid research 2001;42(8):1308-17.
2001: Mehrabian M; Wong J; Wang X; Jiang Z; Shi W; Fogelman A M; Lusis A J
Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia.
Circulation research 2001;89(2):125-30.
2001: Datta G; Chaddha M; Hama S; Navab M; Fogelman A M; Garber D W; Mishra V K; Epand R M; Epand R F; Lund-Katz S; Phillips M C; Segrest J P; Anantharamaiah G M
Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide.
Journal of lipid research 2001;42(7):1096-104.
2001: Dwyer J H; Navab M; Dwyer K M; Hassan K; Sun P; Shircore A; Hama-Levy S; Hough G; Wang X; Drake T; Merz C N; Fogelman A M
Oxygenated carotenoid lutein and progression of early atherosclerosis: the Los Angeles atherosclerosis study.
Circulation 2001;103(24):2922-7.
2001: Parhami F; Tintut Y; Ballard A; Fogelman A M; Demer L L
Leptin enhances the calcification of vascular cells: artery wall as a target of leptin.
Circulation research 2001;88(9):954-60.
2001: Van Lenten B J; Wagner A C; Nayak D P; Hama S; Navab M; Fogelman A M
High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection.
Circulation 2001;103(18):2283-8.
2001: Reddy S; Hama S; Grijalva V; Hassan K; Mottahedeh R; Hough G; Wadleigh D J; Navab M; Fogelman A M
Mitogen-activated protein kinase phosphatase 1 activity is necessary for oxidized phospholipids to induce monocyte chemotactic activity in human aortic endothelial cells.
The Journal of biological chemistry 2001;276(20):17030-5.
2001: Van Lenten B J; Navab M; Shih D; Fogelman A M; Lusis A J
The role of high-density lipoproteins in oxidation and inflammation.
Trends in cardiovascular medicine 2001;11(3-4):155-61.
2001: Reddy S T; Wadleigh D J; Grijalva V; Ng C; Hama S; Gangopadhyay A; Shih D M; Lusis A J; Navab M; Fogelman A M
Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(4):542-7.
2001: Navab M; Berliner J A; Subbanagounder G; Hama S; Lusis A J; Castellani L W; Reddy S; Shih D; Shi W; Watson A D; Van Lenten B J; Vora D; Fogelman A M
HDL and the inflammatory response induced by LDL-derived oxidized phospholipids.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(4):481-8.
2001: Garber D W; Datta G; Chaddha M; Palgunachari M N; Hama S Y; Navab M; Fogelman A M; Segrest J P; Anantharamaiah G M
A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis.
Journal of lipid research 2001;42(4):545-52.
2001: Van Lenten B J; Wagner A C; Navab M; Fogelman A M
Oxidized phospholipids induce changes in hepatic paraoxonase and ApoJ but not monocyte chemoattractant protein-1 via interleukin-6.
The Journal of biological chemistry 2001;276(3):1923-9.
2000: Mehrabian M; Castellani L W; Wen P Z; Wong J; Rithaporn T; Hama S Y; Hough G P; Johnson D; Albers J J; Mottino G A; Frank J S; Navab M; Fogelman A M; Lusis A J
Genetic control of HDL levels and composition in an interspecific mouse cross (CAST/Ei x C57BL/6J).
Journal of lipid research 2000;41(12):1936-46.
2000: Subbanagounder G; Leitinger N; Schwenke D C; Wong J W; Lee H; Rizza C; Watson A D; Faull K F; Fogelman A M; Berliner J A
Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(10):2248-54.
2000: Navab M; Hama S Y; Anantharamaiah G M; Hassan K; Hough G P; Watson A D; Reddy S T; Sevanian A; Fonarow G C; Fogelman A M
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.
Journal of lipid research 2000;41(9):1495-508.
2000: Navab M; Hama S Y; Cooke C J; Anantharamaiah G M; Chaddha M; Jin L; Subbanagounder G; Faull K F; Reddy S T; Miller N E; Fogelman A M
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1.
Journal of lipid research 2000;41(9):1481-94.
2000: Hedrick C C; Hassan K; Hough G P; Yoo J H; Simzar S; Quinto C R; Kim S M; Dooley A; Langi S; Hama S Y; Navab M; Witztum J L; Fogelman A M
Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(8):1946-52.
1999: Ansell B J; Watson K E; Fogelman A M
An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.
JAMA : the journal of the American Medical Association 1999;282(21):2051-7.
1999: Watson A D; Subbanagounder G; Welsbie D S; Faull K F; Navab M; Jung M E; Fogelman A M; Berliner J A
Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein.
The Journal of biological chemistry 1999;274(35):24787-98.
1999: Leitinger N; Watson A D; Hama S Y; Ivandic B; Qiao J H; Huber J; Faull K F; Grass D S; Navab M; Fogelman A M; de Beer F C; Lusis A J; Berliner J A
Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(5):1291-8.
1999: Ivandic B; Castellani L W; Wang X P; Qiao J H; Mehrabian M; Navab M; Fogelman A M; Grass D S; Swanson M E; de Beer M C; de Beer F; Lusis A J
Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(5):1284-90.
1998: Navab M; Hama S Y; Hough G P; Hedrick C C; Sorenson R; La Du B N; Kobashigawa J A; Fonarow G C; Berliner J A; Laks H; Fogelman A M
High density associated enzymes: their role in vascular biology.
Current opinion in lipidology 1998;9(5):449-56.
1998: Shih D M; Gu L; Xia Y R; Navab M; Li W F; Hama S; Castellani L W; Furlong C E; Costa L G; Fogelman A M; Lusis A J
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis.
Nature 1998;394(6690):284-7.
1997: Ishikawa K; Navab M; Leitinger N; Fogelman A M; Lusis A J
Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL.
The Journal of clinical investigation 1997;100(5):1209-16.
1997: Castellani L W; Navab M; Van Lenten B J; Hedrick C C; Hama S Y; Goto A M; Fogelman A M; Lusis A J
Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.
The Journal of clinical investigation 1997;100(2):464-74.
1997: Berliner J; Leitinger N; Watson A; Huber J; Fogelman A; Navab M
Oxidized lipids in atherogenesis: formation, destruction and action.
Thrombosis and haemostasis 1997;78(1):195-9.
1997: Watson A D; Leitinger N; Navab M; Faull K F; Hörkkö S; Witztum J L; Palinski W; Schwenke D; Salomon R G; Sha W; Subbanagounder G; Fogelman A M; Berliner J A
Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo.
The Journal of biological chemistry 1997;272(21):13597-607.
1997: Navab M; Hama-Levy S; Van Lenten B J; Fonarow G C; Cardinez C J; Castellani L W; Brennan M L; Lusis A J; Fogelman A M; La Du B N
Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
The Journal of clinical investigation 1997;99(8):2005-19.
1997: Leitinger N; Watson A D; Faull K F; Fogelman A M; Berliner J A
Monocyte binding to endothelial cells induced by oxidized phospholipids present in minimally oxidized low density lipoprotein is inhibited by a platelet activating factor receptor antagonist.
Advances in experimental medicine and biology 1997;433():379-82.
1996: Navab M; Berliner J A; Watson A D; Hama S Y; Territo M C; Lusis A J; Shih D M; Van Lenten B J; Frank J S; Demer L L; Edwards P A; Fogelman A M
The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(7):831-42.
1996: Uyemura K; Demer L L; Castle S C; Jullien D; Berliner J A; Gately M K; Warrier R R; Pham N; Fogelman A M; Modlin R L
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.
The Journal of clinical investigation 1996;97(9):2130-8.
1996: Shih D M; Gu L; Hama S; Xia Y R; Navab M; Fogelman A M; Lusis A J
Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model.
The Journal of clinical investigation 1996;97(7):1630-9.
1995: Watson A D; Berliner J A; Hama S Y; La Du B N; Faull K F; Fogelman A M; Navab M
Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
The Journal of clinical investigation 1995;96(6):2882-91.
1995: Van Lenten B J; Hama S Y; de Beer F C; Stafforini D M; McIntyre T M; Prescott S M; La Du B N; Fogelman A M; Navab M
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
The Journal of clinical investigation 1995;96(6):2758-67.
1995: Parhami F; Fang Z T; Yang B; Fogelman A M; Berliner J A
Stimulation of Gs and inhibition of Gi protein functions by minimally oxidized LDL.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(11):2019-24.
1995: Navab M; Fogelman A M; Berliner J A; Territo M C; Demer L L; Frank J S; Watson A D; Edwards P A; Lusis A J
Pathogenesis of atherosclerosis.
The American journal of cardiology 1995;76(9):18C-23C.
1995: Van Lenten B J; Prieve J; Navab M; Hama S; Lusis A J; Fogelman A M
Lipid-induced changes in intracellular iron homeostasis in vitro and in vivo.
The Journal of clinical investigation 1995;95(5):2104-10.
1995: Liao F; Andalibi A; Lusis A J; Fogelman A M
Genetic control of the inflammatory response induced by oxidized lipids.
The American journal of cardiology 1995;75(6):65B-66B.
1995: Watson A D; Navab M; Hama S Y; Sevanian A; Prescott S M; Stafforini D M; McIntyre T M; Du B N; Fogelman A M; Berliner J A
Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
The Journal of clinical investigation 1995;95(2):774-82.
1994: Fyfe A I; Stevenson L W; Harper C M; Drinkwater D C; Laks H; Fogelman A M; Berliner J A
Recipient mononuclear cell recognition and adhesion to graft endothelium after human cardiac transplantation. Lymphocyte recognition leads to monocyte adhesion.
The Journal of clinical investigation 1994;94(5):2142-7.
1994: Schwartz D; Andalibi A; Chaverri-Almada L; Berliner J A; Kirchgessner T; Fang Z T; Tekamp-Olson P; Lusis A J; Gallegos C; Fogelman A M
Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium.
The Journal of clinical investigation 1994;94(5):1968-73.
1994: Liao F; Lusis A J; Berliner J A; Fogelman A M; Kindy M; de Beer M C; de Beer F C
Serum amyloid A protein family. Differential induction by oxidized lipids in mouse strains.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(9):1475-9.
1994: Liao F; Andalibi A; Qiao J H; Allayee H; Fogelman A M; Lusis A J
Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice.
The Journal of clinical investigation 1994;94(2):877-84.
1994: Nievelstein-Post P; Mottino G; Fogelman A; Frank J
An ultrastructural study of lipoprotein accumulation in cardiac valves of the rabbit.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(7):1151-61.
1994: Navab M; Hama S Y; Nguyen T B; Fogelman A M
Monocyte adhesion and transmigration in atherosclerosis.
Coronary artery disease 1994;5(3):198-204.
1994: Kim J A; Territo M C; Wayner E; Carlos T M; Parhami F; Smith C W; Haberland M E; Fogelman A M; Berliner J A
Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(3):427-33.
1994: Fyfe A I; Stevenson L W; Berliner J A; Fogelman A M
Antibodies to the T-cell receptor (CD3) induce LFA-1/Mac-1-dependent mononuclear cell adhesion to human arterial endothelium.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1994;13(2):230-5.
1993: Berliner J A; Parhami F; Fang Z T; Fogelman A M; Territo C
Regulation of monocyte and neutrophil entry into the vessel wall.
Behring Institute Mitteilungen 1993;(92):87-91.
1993: Andalibi A; Liao F; Imes S; Fogelman A M; Lusis A J
Oxidized lipoproteins influence gene expression by causing oxidative stress and activating the transcription factor NF-kappa B.
Biochemical Society transactions 1993;21 ( Pt 3)(3):651-5.
1993: Parhami F; Fang Z T; Fogelman A M; Andalibi A; Territo M C; Berliner J A
Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate.
The Journal of clinical investigation 1993;92(1):471-8.
1993: Liao F; Andalibi A; deBeer F C; Fogelman A M; Lusis A J
Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice.
The Journal of clinical investigation 1993;91(6):2572-9.
1993: Navab M; Hama S Y; Van Lenten B J; Drinkwater D C; Laks H; Fogelman A M
A new antiinflammatory compound, leumedin, inhibits modification of low density lipoprotein and the resulting monocyte transmigration into the subendothelial space of cocultures of human aortic wall cells.
The Journal of clinical investigation 1993;91(3):1225-30.
1993: Bennett R L; Navab M; Demer L L; Fogelman A M
A new anti-inflammatory leucine derivative, NPC-15669, inhibits growth of cultured human aortic smooth muscle cells.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(3):360-6.
1993: Berliner J A; Schwartz D S; Territo M C; Andalibi A; Almada L; Lusis A J; Quismorio D; Fang Z P; Fogelman A M
Induction of chemotactic cytokines by minimally oxidized LDL.
Advances in experimental medicine and biology 1993;351():13-8.
1992: Berliner J A; Territo M; Navab M; Andalibi A; Parhami F; Liao F; Kim J; Estworthy S; Lusis A J; Fogelman A M
Minimally modified lipoproteins in diabetes.
Diabetes 1992;41 Suppl 2():74-6.
1992: Bork R W; Svenson K L; Mehrabian M; Lusis A J; Fogelman A M; Edwards P A
Mechanisms controlling competence gene expression in murine fibroblasts stimulated with minimally modified LDL.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1992;12(7):800-6.
1992: Hwa J J; Zollman S; Warden C H; Taylor B A; Edwards P A; Fogelman A M; Lusis A J
Genetic and dietary interactions in the regulation of HMG-CoA reductase gene expression.
Journal of lipid research 1992;33(5):711-25.
1992: Haberland M E; Fless G M; Scanu A M; Fogelman A M
Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages.
The Journal of biological chemistry 1992;267(6):4143-51.
1992: Cushing S D; Fogelman A M
Monocytes may amplify their recruitment into inflammatory lesions by inducing monocyte chemotactic protein.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1992;12(1):78-82.
1992: van Lenten B J; Fogelman A M
Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-alpha.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(1):112-6.
1991: Nievelstein P F; Fogelman A M; Mottino G; Frank J S
Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein. A deep-etch and immunolocalization study of ultrarapidly frozen tissue.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(6):1795-805.
1991: Liao F; Berliner J A; Mehrabian M; Navab M; Demer L L; Lusis A J; Fogelman A M
Minimally modified low density lipoprotein is biologically active in vivo in mice.
The Journal of clinical investigation 1991;87(6):2253-7.
1991: Navab M; Liao F; Hough G P; Ross L A; Van Lenten B J; Rajavashisth T B; Lusis A J; Laks H; Drinkwater D C; Fogelman A M
Interaction of monocytes with cocultures of human aortic wall cells involves interleukins 1 and 6 with marked increases in connexin43 message.
The Journal of clinical investigation 1991;87(5):1763-72.
1991: Mehrabian M; Sparkes R S; Mohandas T; Fogelman A M; Lusis A J
Localization of monocyte chemotactic protein-1 gene (SCYA2) to human chromosome 17q11.2-q21.1.
Genomics 1991;9(1):200-3.
1990: Hough G P; Ross L A; Navab M; Fogelman A M
Transport of low density lipoproteins across endothelial monolayers.
European heart journal 1990;11 Suppl E():62-71.
1990: Van Lenten B J; Fogelman A M
Processing of lipoproteins in human monocyte-macrophages.
Journal of lipid research 1990;31(8):1455-66.
1990: Cushing S D; Berliner J A; Valente A J; Territo M C; Navab M; Parhami F; Gerrity R; Schwartz C J; Fogelman A M
Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(13):5134-8.
1990: Berliner J A; Territo M C; Sevanian A; Ramin S; Kim J A; Bamshad B; Esterson M; Fogelman A M
Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.
The Journal of clinical investigation 1990;85(4):1260-6.
1990: Rajavashisth T B; Andalibi A; Territo M C; Berliner J A; Navab M; Fogelman A M; Lusis A J
Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins.
Nature 1990;344(6263):254-7.
1989: Territo M C; Berliner J A; Almada L; Ramirez R; Fogelman A M
Beta-very low density lipoprotein pretreatment of endothelial monolayers increases monocyte adhesion.
Arteriosclerosis (Dallas, Tex.) 1989;9(6):824-8.
1989: Frank J S; Fogelman A M
Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching.
Journal of lipid research 1989;30(7):967-78.
1988: Navab M; Hough G P; Stevenson L W; Drinkwater D C; Laks H; Fogelman A M
Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells.
The Journal of clinical investigation 1988;82(6):1853-63.
1988: Fogelman A M; Elahi F; Sykes K; Van Lenten B J; Territo M C; Berliner J A
Modification of the Recalde method for the isolation of human monocytes.
Journal of lipid research 1988;29(9):1243-7.
1988: Thomas D D; Navab M; Haake D A; Fogelman A M; Miller J N; Lovett M A
Treponema pallidum invades intercellular junctions of endothelial cell monolayers.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(10):3608-12.
1988: Fogelman A M; Berliner J A; Van Lenten B J; Navab M; Territo M
Lipoprotein receptors and endothelial cells.
Seminars in thrombosis and hemostasis 1988;14(2):206-9.
1988: Navab M; Hough G P; Van Lenten B J; Berliner J A; Fogelman A M
Low density lipoproteins transfer bacterial lipopolysaccharides across endothelial monolayers in a biologically active form.
The Journal of clinical investigation 1988;81(2):601-5.
1988: Fogelman A M; Van Lenten B J; Warden C; Haberland M E; Edwards P A
Macrophage lipoprotein receptors.
Journal of cell science. Supplement 1988;9():135-49.
1987: Clarke C F; Tanaka R D; Svenson K; Wamsley M; Fogelman A M; Edwards P A
Molecular cloning and sequence of a cholesterol-repressible enzyme related to prenyltransferase in the isoprene biosynthetic pathway.
Molecular and cellular biology 1987;7(9):3138-46.
1986: Mehrabian M; Callaway K A; Clarke C F; Tanaka R D; Greenspan M; Lusis A J; Sparkes R S; Mohandas T; Edmond J; Fogelman A M
Regulation of rat liver 3-hydroxy-3-methylglutaryl coenzyme A synthase and the chromosomal localization of the human gene.
The Journal of biological chemistry 1986;261(34):16249-55.
1986: Navab M; Hough G P; Berliner J A; Frank J A; Fogelman A M; Haberland M E; Edwards P A
Rabbit beta-migrating very low density lipoprotein increases endothelial macromolecular transport without altering electrical resistance.
The Journal of clinical investigation 1986;78(2):389-97.
1986: Berliner J A; Territo M; Almada L; Carter A; Shafonsky E; Fogelman A M
Monocyte chemotactic factor produced by large vessel endothelial cells in vitro.
Arteriosclerosis (Dallas, Tex.) 1986;6(3):254-8.
1986: Edwards P A; Lan S F; Fogelman A M
The effect of glucagon on the synthesis and degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Journal of lipid research 1986;27(4):398-403.
1986: Van Lenten B J; Fogelman A M; Haberland M E; Edwards P A
The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(8):2704-8.
1985: Van Lenten B J; Fogelman A M; Jackson R L; Shapiro S; Haberland M E; Edwards P A
Receptor-mediated uptake of remnant lipoproteins by cholesterol-loaded human monocyte-macrophages.
The Journal of biological chemistry 1985;260(15):8783-8.
1985: Phelan J P; Van Lenten B J; Fogelman A M; Kean C; Haberland M E; Edwards P A
Notes on the breeding of the WHHL rabbit: an animal model of familial hypercholesterolemia.
Journal of lipid research 1985;26(6):776-8.
1985: Van Lenten B J; Fogelman A M; Seager J; Ribi E; Haberland M E; Edwards P A
Bacterial endotoxin selectively prevents the expression of scavenger-receptor activity on human monocyte-macrophages.
Journal of immunology (Baltimore, Md. : 1950) 1985;134(6):3718-21.
1984: Edwards P A; Lan S F; Fogelman A M
High density lipoproteins and lecithin dispersions increase the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase by increasing the rate of synthesis and decreasing the rate of degradation of the enzyme.
The Journal of biological chemistry 1984;259(13):8190-4.
1984: Baker D P; Van Lenten B J; Fogelman A M; Edwards P A; Kean C; Berliner J A
LDL, scavenger, and beta-VLDL receptors on aortic endothelial cells.
Arteriosclerosis (Dallas, Tex.) 1984;4(3):248-55.
1983: Fogelman A M; Seager J; Groopman J E; Berliner J A; Haberland M E; Edwards P A; Golde D W
Lymphokines secreted by an established lymphocyte line modulate receptor-mediated endocytosis in macrophages derived from human monocytes.
Journal of immunology (Baltimore, Md. : 1950) 1983;131(5):2368-73.
1983: Tanaka R D; Edwards P A; Lan S F; Fogelman A M
Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in avian myeloblasts. Mode of action of 25-hydroxycholesterol.
The Journal of biological chemistry 1983;258(21):13331-9.
1983: Edwards P A; Lan S F; Fogelman A M
Alterations in the rates of synthesis and degradation of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase produced by cholestyramine and mevinolin.
The Journal of biological chemistry 1983;258(17):10219-22.
1983: Edwards P A; Lan S F; Tanaka R D; Fogelman A M
Mevalonolactone inhibits the rate of synthesis and enhances the rate of degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in rat hepatocytes.
The Journal of biological chemistry 1983;258(12):7272-5.
1983: Clarke C F; Edwards P A; Lan S F; Tanaka R D; Fogelman A M
Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase mRNA levels in rat liver.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(11):3305-8.
1983: Van Lenten B J; Fogelman A M; Hokom M M; Benson L; Haberland M E; Edwards P A
Regulation of the uptake and degradation of beta-very low density lipoprotein in human monocyte macrophages.
The Journal of biological chemistry 1983;258(8):5151-7.
1982: Fogelman A M; Hokom M M; Haberland M E; Tanaka R D; Edwards P A
Lipoprotein regulation of cholesterol metabolism in macrophages derived from human monocytes.
The Journal of biological chemistry 1982;257(23):14081-6.
1982: Tanaka R D; Edwards P A; Lan S F; Knöppel E M; Fogelman A M
The effect of cholestyramine and Mevinolin on the diurnal cycle of rat hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Journal of lipid research 1982;23(7):1026-31.
1982: Tanaka R D; Edwards P A; Lan S F; Knöppel E M; Fogelman A M
Purification of 3-hydroxy-3-methylglutaryl coenzyme A reductase from human liver.
Journal of lipid research 1982;23(4):523-30.
1982: Fogelman A M; Seager J; Haberland M E; Hokom M; Tanaka R; Edwards P A
Lymphocyte-conditioned medium protects human monocyte-macrophages from cholesteryl ester accumulation.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(3):922-6.
1981: Fogelman A M; Haberland M E; Seager J; Hokom M; Edwards P A
Factors regulating the activities of the low density lipoprotein receptor and the scavenger receptor on human monocyte-macrophages.
Journal of lipid research 1981;22(7):1131-41.
1981: Shechter I; Fogelman A M; Haberland M E; Seager J; Hokom M; Edwards P A
The metabolism of native and malondialdehyde-altered low density lipoproteins by human monocyte-macrophages.
Journal of lipid research 1981;22(1):63-71.
1980: Fogelman A M; Shechter I; Seager J; Hokom M; Child J S; Edwards P A
Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(4):2214-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Alan Fogelman

Research Profile (preview)

Chemicals & Drugs

Anatomy

Living Beings

Disorders

Phenomena

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Alan Fogelman (preview)

All Publications